Holen Sie sich die Stockscreener-App
25.34
0.55%
-0.14
Vorhandelsmarkt:
25.21
-0.13
-0.51%
Schlusskurs vom Vortag:
$25.48
Offen:
$25.48
24-Stunden-Volumen:
5.32M
Relative Volume:
0.94
Marktkapitalisierung:
$12.66B
Einnahmen:
$4.89B
Nettoeinkommen (Verlust:
$-242.00M
KGV:
-51.82
EPS:
-0.489
Netto-Cashflow:
$315.00M
1W Leistung:
-0.78%
1M Leistung:
+6.03%
6M Leistung:
+1.73%
1J Leistung:
+69.73%
1-Tages-Spanne:
$25.23
$25.95
1-Wochen-Bereich:
$25.04
$26.37
52-Wochen-Spanne:
$13.39
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
25.34 | 12.66B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
16.87 | 53.87B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.85 | 43.38B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.15 | 35.11B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
74.19 | 31.10B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.07 | 26.25B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
ELAN Maintained by Morgan Stanley -- Price Target Raised to $26. - GuruFocus
Morgan Stanley Issues Positive Forecast for Elanco Animal Health (NYSE:ELAN) Stock Price - MarketBeat
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great Choice - Yahoo Finance
Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside - TradingView
Elanco’s Credelio Quattro shows faster tick kill in study By Investing.com - Investing.com Canada
Elanco's Credelio Quattro Maintains 8-Hour Tick Kill Through Day 28 - Stock Titan
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Dimensional Fund Advisors LP Has $586.92 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
LLY4841184 Bond Profile — Key Metrics - TradingView
Jennison Associates LLC Purchases 494,216 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Principal Financial Group Inc. Grows Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
472,814 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Dorsey Wright & Associates - MarketBeat
Allspring Global Investments Holdings LLC Acquires New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
KIN stock trades quietly as Kindred Biosciences acquisition leaves legacy metrics in focus - ad-hoc-news.de
Geneos Wealth Management Inc. Purchases 196,884 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Fifth Third Bancorp Grows Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Ends Apollo Government Relations Lobbying Deal - Legis1
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Elanco Animal Health (NYSE: ELAN) awards CEO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards CFO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards deferred stock units to company officer - Stock Titan
Dimensional Fund Advisors reports 5.1% Elanco Animal Health (ELAN) stake - Stock Titan
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How Elanco Helped Puppies Fight Parvo - CSRwire
Form 4 Elanco Animal Health For: 9 July By Investing.com - Investing.com Nigeria
Elanco (NYSE: ELAN) CFO uses 15,336 shares to cover tax liability - Stock Titan
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement - GuruFocus
Elanco sets Aug. 5 call for second-quarter 2026 results - Stock Titan
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health - AOL.com
Integrated Advisors Network LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Strs Ohio Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
SG Americas Securities LLC Reduces Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - TMX Newsfile
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco A - GuruFocus
Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality - ChartMill
Form 4 Elanco Animal Health For: 2 July By Investing.com - Investing.com Nigeria
Elanco (ELAN) executive awarded 25,620 stock options at $24.09 strike price - Stock Titan
Elanco (ELAN) director converts cash fees into 584 deferred stock units - Stock Titan
Form 4 Elanco Animal Health For: 30 June By Investing.com - Investing.com Canada
Elanco (NYSE: ELAN) executive receives new deferred stock unit award - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives 115 deferred stock units grant - Stock Titan
Elanco (NYSE: ELAN) CFO gets new deferred stock unit award - Stock Titan
Elanco Commits To Supporting US In Fight Against Screwworm - InkFreeNews.com
Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance
Enterprise value to EBIT forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Piper Sandler reiterates Elanco stock rating on defensive positioning By Investing.com - Investing.com Canada
Piper Sandler Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Price to sales forward of Elanco Animal Health, Inc. – MUN:5EA - TradingView
Price to earnings forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Enterprise value to EBITDA forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Enterprise value to revenue forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
9.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):